Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on Summit Therapeutics (NASDAQ:SMMT), citing an unfavorable ...
GitLab Inc. (NASDAQ:GTLB) is one of the AI Stocks Analysts are Tracking Closely. On November 10, Piper Sandler analyst Rob Owens reiterated an Overweight rating on the stock with a $70.00 price target ...
Investing.com -- Dell shares have edged lower premarket after Piper Sandler flagged a challenging outlook for the company amid rising component costs and mixed expectations for its upcoming earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results